By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Currency | US Dollars |
Share Price | $ 845.72 |
Change Today | $ 2.09 |
% Change | 0.25 % |
52 Week High | $932.06 |
52 Week Low | $625.65 |
Volume | 2,615 |
Shares Issued | 948.17m |
Market Cap | $801,886m |
Beta | 0.69 |
RiskGrade | 179 |
You are here: research